What Cedaris does

Cedaris (legally Cedaris.ai) is a Singapore-headquartered private software company that builds an AI platform for pharmaceutical and chemical manufacturers. The platform combines high-fidelity process simulation (digital twins), machine-learning-based predictive analytics, continuous optimisation of process parameters, and a market and regulatory intelligence module, and is delivered as a SaaS subscription. It is organised into three verticalised use case modules — Pharma Manufacturing (real-time process simulation, AI-powered quality control, regulatory compliance automation, yield improvement, MES/ERP integration), Lab of the Future (automated experiment design, AI-assisted data analysis, instrument scheduling, digital lab notebook, predictive maintenance), and Agile Factory (modular facility design with AI layout optimisation, demand-driven scheduling, energy efficiency and sustainability analytics, supply chain disruption prediction, closed-loop continuous improvement). Functional benefits claimed include waste reduction, shorter batch cycle times, improved yield, automated quality control, and predictive maintenance.

Cedaris targets four vertical segments — pharmaceutical manufacturers, R&D laboratories, agile/modular manufacturing facilities, and chemical manufacturers — and sells via an enterprise field-sales motion with 'Request a demo' and 'Get in touch' CTAs on its website (no public pricing). The company positions a domain-expert, science-first approach and emphasises sustainability integration and global access across emerging and established pharma markets. The stated value proposition is an AI platform that unifies data from lab bench to factory floor into a single learning layer that optimises manufacturing efficiency, compliance, and sustainability outcomes simultaneously.

Commercially, Cedaris is at a very early stage: 1-10 employees, no disclosed funding rounds, no named customers or case studies, no management team disclosed, no pricing page, and no partnerships or awards on record. The website is operational and productised as of 2026, with global presence anchored out of an Asia Pacific HQ, but the absence of disclosed revenue, customers, or capital limits confidence in any commercial trajectory assessment.

Name

Cedaris

Legal name

Cedaris.ai

Website

https://cedaris.ai

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Cedaris (Cedaris.ai) is a Singapore-based private company that sells a subscription AI platform for process simulation, predictive analytics, and optimisation to pharmaceutical and chemical manufacturers across pharma manufacturing, R&D labs, and agile/modular factory operations.

Ownership category

akta.pro rank

Headquarters

HQ city

Singapore

HQ country

Singapore

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. AI Platform Subscription: SaaS-based AI platform delivery model providing process simulation, predictive analytics, and optimization capabilities to pharmaceutical and chemical manufacturers on a subscription basis.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Cedaris provides an AI-powered software platform that delivers process simulation, predictive analytics, and intelligent optimization for pharmaceutical and chemical manufacturers. The platform integrates with existing MES and ERP systems to reduce waste, accelerate batch cycle times, ensure regulatory compliance, and improve yield across API production, laboratory operations, and modular manufacturing facilities.

Product overview

Cedaris offers a unified AI platform (Cedaris AI Platform) with integrated modules for pharmaceutical and chemical manufacturing intelligence. The platform comprises five core features: Process Simulation (digital twins for manufacturing), Predictive Analytics (ML-based outcome forecasting), Intelligent Optimisation (real-time parameter adaptation), and Market & Regulatory Intelligence (automated research and compliance). These are delivered through three use case modules — Pharma Manufacturing, Lab of the Future, and Agile Factory — which apply the platform's AI capabilities to specific operational areas across the pharmaceutical manufacturing lifecycle from lab bench to factory floor.

Differentiator

Problem solved

Functional benefit

Products and services

• Cedaris AI Platform

Quantifiable outcome

• Reduces waste in manufacturing processes
• +3 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature10 records

Scale indicators2 records

Recent moves4 records

Expansion highlights5 records

Broad incumbents

• Siemens: Siemens offers gPROMS process modeling and Opcenter manufacturing operations software, alongside broader automation and digital-enterprise capabilities. It is a broad incumbent with comparable process simulation, analytics, and factory-integration functionality.
• AVEVA: AVEVA provides industrial data management, process optimization, digital twin, and MES software for process manufacturing. It is a broad incumbent that overlaps with Cedaris's predictive process analytics and manufacturing-integration proposition.
• Dassault Systèmes: Dassault Systèmes' BIOVIA, DELMIA, and modeling products support pharmaceutical R&D, process design, and manufacturing digital continuity. It is a broad incumbent comparable through lab informatics, simulation, and factory optimization.

Emerging players

• Benchling: Benchling is a cloud R&D platform for biotechnology and pharmaceutical teams, supporting experiment design, data capture, analysis, and collaboration. It is an emerging peer for Cedaris's Lab of the Future use case, but it is more concentrated in research workflows than factory optimization.
• Braincube: Braincube applies AI and digital-twin technology to manufacturing operations, with capabilities in process optimization, anomaly detection, and performance improvement. It is an emerging peer with a similar industrial-AI and operational-optimization orientation.
• Tulip: Tulip provides a composable manufacturing operations platform and frontline applications for regulated and complex production environments. It is an emerging peer for Cedaris's factory-floor software, process monitoring, and workflow digitization, though it is less focused on scientific simulation.
• Seeq: Seeq offers industrial analytics and AI software for time-series process data, including anomaly detection, monitoring, and predictive insights. It is an emerging peer for Cedaris's predictive analytics and optimization of manufacturing process data.

Direct peers

• Körber: Körber's PAS-X manufacturing execution platform is used for regulated pharmaceutical and life-sciences production, with batch, quality, and compliance workflows. It is a direct peer at the manufacturing-operations layer even though Cedaris emphasizes AI simulation and optimization.
• Veeva Systems: Veeva Systems provides cloud software for life sciences, including manufacturing, quality, regulatory, and clinical workflows. It is a direct enterprise-platform peer for pharma customers, although its core footprint is broader business applications than process simulation.
• AspenTech: AspenTech provides process simulation, optimization, digital twins, and industrial analytics for process industries, including chemical and pharmaceutical manufacturing. Its Aspen Plus and related manufacturing software overlap directly with Cedaris's simulation and optimization focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/cedaris-pte-ltd

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cedaris